Clinical Trial Update: Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy [NA]

View source ↗

Summary

The trial update reports that short-term anastrozole therapy reduced cellular proliferation and progesterone receptor indexes in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Breast Cancer | NA | Status: COMPLETED